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Thymocytes and thymic epithelial cells (TECs) cross-talk is essential to supportT cell devel-
opment and preserve thymic architecture and maturation of TECs and Foxp3+ natural
regulatory T cells. Accordingly, disruption of thymic lymphostromal cross-talk may have
major implications on the thymic mechanisms that governT cell tolerance. Several genetic
defects have been described in humans that affect early stages ofT cell development [lead-
ing to severe combined immune deficiency (SCID)] or late stages in thymocyte maturation
(resulting in combined immunodeficiency). Hypomorphic mutations in SCID-causing genes
may allow for generation of a limited pool of T lymphocytes with a restricted repertoire.
These conditions are often associated with infiltration of peripheral tissues by activated T
cells and immune dysregulation, as best exemplified by Omenn syndrome (OS). In this
review, we will discuss our recent findings on abnormalities of thymic microenvironment
in OS with a special focus of defective maturation of TECs, altered distribution of thymic
dendritic cells and impairment of deletional and non-deletional mechanisms of central tol-
erance. Here, taking advantage of mouse models of OS and atypical SCID, we will discuss
how modifications in stromal compartment impact and shape lymphocyte differentiation,
and vice versa how inefficientT cell signaling results in defective stromal maturation.These
findings are instrumental to understand the extent to which novel therapeutic strategies
should act on thymic stroma to achieve full immune reconstitution.
Keywords: thymus, Rag deficiency, Omenn and leaky SCID models, central tolerance, thymic reconstitution, thymic
cross-talk
INTRODUCTION
Thymocytes and thymic epithelial cells (TECs) cross-talk is essen-
tial to support T cell development and preserve thymic architecture
and maturation of TECs and Foxp3+ natural regulatory T (nTreg)
cells. In particular, deletion of self-reactive thymocytes in the
thymic medulla is based on the recognition of self-antigens that
are presented by medullary TECs (mTECs) and thymic dendritic
cells (DCs). In this process, a key role is played by the autoimmune
regulator (AIRE), a transcription factor expressed by a subset of
mature mTEC that drives the expression of tissue-restricted anti-
gens (TRAs), thus mediating negative selection of autoreactive
thymocytes (1, 2). In addition, mature TECs from the Hassall cor-
puscles secrete thymic stromal lymphopoietin (TSLP), a cytokine
that acts through thymic DCs and activates them to instruct self-
reactive T cells to be diverted into Foxp3+ nTreg cells (3). These
findings highlight the critical role played by the thymus not only in
the generation of a diversified and functional T cell repertoire, but
also in the prevention of autoimmune manifestations. To this end,
defects in T cell development represent a valuable model for study-
ing mechanisms by which severe impairment in thymopoiesis may
impinge on thymic stromal cell homeostasis and deletional and
non-deletional mechanisms (4). In particular, severe combined
immune deficiency (SCID) includes a heterogeneous group of
genetic disorders that abolish T cell development at early stage of
T cell differentiation by affecting survival of lymphoid progenitors
(as in adenosine deaminase deficiency and reticular dysgenesis),
interleukin (IL)-mediated expansion of lymphoid progenitors (as
in patients with mutations in the γ common chain, JAK3, or IL-7
receptor), V(D)J recombination [as in recombination activating
gene (Rag)1 and 2, and Artemis deficiency] in lymphoid pre-
cursors and signaling through the pre-T cell receptor (mutations
of CD3δ, CD3ε, CD3ζ, and CD45) (5). Null mutations in these
SCID-causing genes are associated with a virtual lack of circu-
lating T lymphocytes. However, hypomorphic mutations in the
same genes may allow for development of a restricted number
of T lymphocytes with limited repertoire diversity, which, when
exported to the periphery, may infiltrate target tissues and cause
autoimmunity and organ dysfunction, as in patients with Omenn
syndrome (OS) (6–10). Finally, defects in T cell development that
compromise thymocyte development beyond the CD4+ CD8+
[double-positive (DP)] stage result in combined immunodefi-
ciency with residual number of circulating T lymphocytes that
show abnormal phenotype and function. In particular, impaired
production of single-positive (SP) CD4+ cells is observed in major
histocompatibility complex (MHC) class II deficiency, whereas
generation of SP CD8+ lymphocytes is compromised in ZAP70
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deficiency (11, 12). Association of these conditions with immune
dysregulation has been reported, although not as frequently as in
OS due to hypomorphic mutations in SCID-causing genes (13).
In this review, we will focus the discussion on the contribution
of thymic microenvironment on the pathogenesis of peripheral
immune pathology in the presence of residual V(D)J recombi-
nation activity. To this end, we will discuss findings observed in
Rag2R229Q/R229Q and Rag1S723C/S723C mutant mice, which repre-
sent a valuable model of OS and atypical SCID, respectively (14–
18). Collectively, we provide evidence that abnormalities of thymic
stroma secondary to impaired development of T lymphocytes may
affect key mechanisms of immune tolerance and ultimately result
in severe manifestations of immune dysregulation.
MOUSE MODELS OF LEAKY SCID AND OS
Mutations of Rag genes result in a variety of clinical and immuno-
logical phenotypes. In particular, while null mutations cause a
severe block in T and B cell development (T− B− SCID), hypo-
morphic Rag1 and Rag2 mutations may cause a spectrum of
phenotypes, including OS, atypical SCID, combined immune
deficiency with expansion of TCRαβ+ T cells, and combined
immune deficiency with granuloma and/or autoimmunity (CID-
G/A) despite their common molecular mechanisms underlying
the disease (19–25). While all of these conditions associated with
hypomorphic Rag mutations are characterized by residual devel-
opment of T (and in some cases, B) lymphocytes, some of them
(especially OS and CID-G/A) present with prominent immune
dysregulation. However, the cellular and molecular mechanisms
underlying autoimmunity have remained poorly defined until
recently, when animal models of OS and leaky SCID have become
available (16, 17, 26). In particular, Khiong and colleagues have
reported on a spontaneously occurring mouse mutant (named
MM) in which a homozygous point mutation in the Rag1 gene
(R972Q) was associated with a high proportion of memory T
cells in the periphery. Although MM mice showed skin redness
when shaved, no T cells infiltration was observed in the tissues
and no obvious signs were reported, making this mutant strain a
model of leaky SCID, in which T and B cells are present in low
number and T cells are predominantly activated, but no obvi-
ous signs of autoimmunity are present (26). In another mouse
model, homozygosity for the Rag1 S721C mutation was associ-
ated with impaired T cell development, presence of oligoclonal,
activated T cells, profound B cell lymphopenia, and yet signif-
icant serum levels of immunoglobulin (15, 17, 18). Although
only a minority of Rag1S723C/S723C mice developed signs of OS, T
cell infiltrates in peripheral tissues, and autoantibodies to double
stranded DNA (dsDNA) and other self-antigens were demon-
strated in a significant proportion of mutant mice 15. Immune
dysregulation was even more prominent in another mutant mouse
model carrying a homozygous Rag2 R229Q mutation, as shown
by expansion of oligoclonal activated T cells infiltrating target
organs including skin, gut, liver, and lung and by the presence
of high IgE serum levels and autoantibodies, despite the absence
of circulating B cells (14, 16). Of note, immune dysregulation in
Rag1S723C/S723C and Rag2R229Q/R229Q mutants was associated with
profound thymic abnormalities, with lack of corticomedullary
demarcation (CMD), and impaired maturation of TECs (17, 27).
In particular, both Rag1S723C/S723C and Rag2R229Q/R229Q mice dis-
played altered maturation of mTECs, as indicated by the virtual
absence of expression of claudin-4 (Cld4) and Ulex europaeus
Agglutinin 1 (UEA-1) ligand. Furthermore, analysis of cytok-
eratin (CK) expression in the thymus revealed abundance of
CK8+ CK5+ cells, which represent immature TEC progenitors
and a severe reduction of CK8− CK5+ mTECs. FACS analysis
labeling CD45− Epcam+ thymic stromal cells with UEA-1 and
Ly51 specific antibodies for mTECs and cTECs, respectively, have
demonstrated the increased frequency of cTECs with consequent
reduction in mTEC compartment in Rag2R229Q/R229Q mouse com-
pared to WT (Figure 1A). However, all epithelial populations were
significantly diminished in number given the dramatic reduction
in total thymic cellularity (Figure 1B). Defective maturation of
mTECs in Rag1S723C/S723C and Rag2R229Q/R229Q mice was associ-
ated with severe reduction of AIRE-expressing cells and markedly
reduced expression of TRAs, such as cytochrome P450, insulin
2, glutamic acid decarboxylase 67, and fatty acid-binding pro-
teins (17, 27). These defects inevitably lead to a severe impair-
ment in the process of negative selection of autoreactive T cells
clones.
Unexpectedly, abnormalities of thymic DCs, which are involved
in promoting negative selection of self-reactive thymocytes and
in the generation of nTregs, were also demonstrated in both
mutant models. In particular, a relative abundance of CD11cint
CD45RA+ plasmacytoid DCs (pDCs), and a decreased proportion
of CD11c+ CD45RA− conventional DCs (cDCs) was demon-
strated in Rag1S723C/S723C mice (17). A severe reduction of both
cDCs and pDCs was demonstrated in Rag2R229Q/R229Q mice, and
was associated with a random distribution of these DC subsets
throughout the thymus. Furthermore, a significant reduction in
the expression of MHC-II and CD86 was found in both DC sub-
set populations, suggesting impairment in DC maturation process
(28). Of note, impaired maturation of mTECs, defective expres-
sion of AIRE and reduced number of thymic DCs have been
also reported in patients with hypomorphic mutations of genes
involved in early stages of T cell development (29, 30). While
the mechanisms accounting for thymic DC abnormalities in mice
and patients with hypomorphic Rag mutations remain poorly
defined, they have important consequences on maintenance of
immune homeostasis. In particular, cDCs have been described to
contribute to the generation of nTregs (31). Consistent with this, a
reduced number of Foxp3+ nTreg cells have been observed in both
Rag1S723C/S723C and Rag2R229Q/R229Q mice, as well as in patients
with Rag-dependent OS (16, 17, 30).
Altogether, the study of animal models carrying hypomor-
phic Rag mutations has demonstrated that defective T cell lym-
phopoiesis affects maturation and function of thymic stroma, and
impinges on both deletional and non-deletional mechanisms of
immune tolerance, thereby providing important insights on the
pathophysiology of OS.
ANIMAL STUDIES TO TARGET THYMIC STROMA IN Rag
DEFICIENCIES
GENE THERAPY IN Rag1 KNOCK-OUT MICE
An additional demonstration of the importance of thymic
lymphostromal cross-talk has been provided by recent data
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FIGURE 1 |Thymic epithelial cell alterations in Rag2R229Q/R229Q mouse.
(A) Representative FACS analysis of thymic epithelial compartment defined
as Epcam+ cells in the CD45 negative fraction obtained after enzymatic
digestion and enriched through AUTOMACS selection. Digested cells were
stained with specific antibodies (Ly51, UEA-1, and MCH-II) to identify the
different epithelial subsets as indicated in the dot-plots. Numbers represent
the percentage within the indicated regions. (B) Graphic representation of
absolute numbers for each epithelial population obtained upon enzymatic
digestion in all mice analyzed (WT, n=5; Rag2R229Q/R229Q, n= 9). Groups
were analyzed with Prism software (GraphPad) using a two-tailed
Mann–Whitney unpaired test. Data are presented as mean±SD. P -values
of <0.05 were considered significant.
demonstrating that inefficient T cell reconstitution following gene
therapy in Rag 1 deficient mice results in an OS-like phenotype
(32). In this particular model, the majority of Rag1 knock-out
(KO) mice treated with lentiviral vectors carrying codon optimized
human Rag1 cDNA driven by ubiquitous and cell type-restricted
promoters showed low level of T cell reconstitution. In this setting
of T cell lymphopenia, homeostatic proliferation led to peripheral
T cell expansion, associated with a restricted T cell repertoire and a
tendency of T cells to infiltrate peripheral tissues such as skin, lung,
and kidney. Impaired T cell reconstitution, with reduced thymic
cellularity, led to only partial rescue of thymic stroma morphol-
ogy and maturation, with focal areas of CMD and low number
of mature mTECs expressing AIRE. By contrast, transplantation
of wild-type bone marrow cells into Rag1−/− mice leads to the
rescue of thymopoiesis and thymic stroma architecture, with pres-
ence of a well-defined CMD and a normal distribution of cTEC,
immature and mature TEC expressing UEA-1 ligand and AIRE.
Of note, 2 months after treatment, 50% of gene therapy-treated
mice started to develop skin rash and wasting syndrome, which
in some cases led to death. Poor thymic reconstitution correlated
with massive lymphocytic infiltrates in peripheral tissues and pres-
ence of activated (CD44+CD69+) T cells, despite the presence
of Foxp3+ cells. Moreover, gene therapy-treated mice showed a
significant increase in serum IgE levels, presence of anti-dsDNA
antibodies and increased BAFF levels, which represent typical bio-
markers of immune dysregulation in patients and animal models
of OS (14, 18). These data indicate that inadequate rescue of Rag1
expression leads to poor reconstitution of T and B cells and is
insufficient to restore thymic stroma architecture, maturation of
AIRE and TSA-expressing mTECs, and induction of both T and
B cell tolerance. In this scenario, development of a limited num-
ber of T and B lymphocytes and inability to maintain efficient
tolerance checkpoints lead to the development of OS-like mani-
festations. Overall, these data illustrate the importance of T cell
reconstitution for restoring the differentiation and maturation of
TECs, and emphasize the relevance of thymic stroma in ensuring
immune tolerance and preventing thymic egress of autoreactive T
cell clones.
ANTI-CD3ε mAb TREATMENT IN Rag2R229Q/R229Q MOUSE MODEL OF OS
As previously described, OS is an atypical SCID in which the
coexistence of immunodeficiency and autoimmunity remains an
intriguing aspect that needs to be further investigated. Thanks to
availability of the Rag2R229Q/R229Q mouse model, we have stud-
ied various mechanisms that contribute to the pathogenesis of
autoimmune manifestations of OS. We have demonstrated that
in addition to hypomorphic Rag defect leading to generation of
a limited number of T cells, severe defects in thymic epithelial
compartment occur, which contribute to the escape of autore-
active T cells that invade the periphery triggering autoimmunity
(24). This model represents also a valuable tool to evaluate the
effects of TCR signaling on maturation of the thymic stromal
compartment. To this end, we evaluated the in vivo effect of anti-
CD3ε monoclonal antibody (mAb) administration in neonatal
and adult mice. While no significant changes were noticed in
the thymus of adult treated mice, injection of anti-CD3ε mAb
at neonatal age resulted in a dramatic amelioration of the epithe-
lial compartment and peripheral immunopathology. In partic-
ular, treatment was associated with a marked reduction in the
frequency of effector/memory T cells in the periphery and a
significant decrease in interferon-γ (IFN-γ) and tumor necro-
sis factor-α (TNF-α) production by peripheral T cells. These
changes were paralleled by significant modification in thymus
morphology, with appearance of distinct areas of CMD and sig-
nificant improvement of the medullary/cortical ratio (27). Double
staining for CK5 and CK8 further confirmed these findings by
revealing the presence of well-defined cortical and medullary
areas showing that anti-CD3ε mAb treatment enforces matura-
tion of TECs leading to compartmentalization of CK8+CK5−
cTECs and CK8−CK5+ mTECs (Figure 2A). Moreover, we have
described an increase in the presence of UEA-1+ cells, although
the formation of UEA-1+ mature mTECs clusters was not fully
restored.
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FIGURE 2 | Anti-CD3ε mAb administration enhances thymic epithelium
compartmentalization and maturation and modifies thymic DCs
frequency and distribution in Rag2R229Q/R229Q newborns. (A) Left panel
shows representative immunohistochemistry from WT thymus displaying a
well-defined corticomedullary differentiation and normal
compartmentalization of CK8+CK5− cTECs (CK8, blue) and CK8−CK5+
mTECs (CK5, brown). mTECs show mature morphology with large
cytoplasm and delicate CK5 positivity with rare double-positive CK8+CK5+
immature TECs disposed along the corticomedullary junction (asterisk
within inset). Corticomedullary differentiation and maturation of TECs are
profoundly impaired in Rag2R229Q/R229Q mouse (middle panel) in which
immature TECs expressing both CK5 and CK8 are highly represented
(asterisk within inset). Anti-CD3ε mAb administration enforces maturation of
TECs leading to compartmentalization of CK8+CK5− cTECs and CK8−CK5+
mTECs (right panel), although mTECs are still closely packed and irregularly
distributed with intense CK5 positivity as compared to the normal medulla
(detail of morphology within inset). Double immunohistochemical staining:
CK5 (brown staining) and CK8 (blue staining). (m, medulla; c, cortex; scale
bars corresponds to 200 and 50µm for 10× and 40× (insets) original
magnification, respectively). (B) Graphic representation of the percentage
and absolute number of CD11c+ cells in the thymus of all mice analyzed
(WT, n=7; Rag2R229Q/R229Q, n=7; Rag2R229Q/R229Q + anti-CD3 n=9). The last
graph on the right indicates mean fluorescence intensity (MFI) of MHC-II
expression on total CD11c+ cells in all mice analyzed (WT, n=5;
Rag2R229Q/R229Q, n= 6; Rag2R229Q/R229Q + anti-CD3 n=4). (C) Representative
dot plot indicating the distribution of myeloid (CD8−) and lymphoid (CD8+)
populations in the gate of CD11c+ cells (upper panel). Statistics of the
percentage and the absolute numbers of CD8+ and CD8− CD11c+ in all mice
analyzed (WT, n=5; Rag2R229Q/R229Q, n=4; Rag2R229Q/R229Q + anti-CD3 n=4)
(lower panel). Groups were analyzed with Prism software (GraphPad) using
a two-tailed Mann–Whitney unpaired test. Data are presented as
mean±SD. P -values of <0.05 were considered significant.
Furthermore, treatment with anti-CD3ε mAb normalized the
frequency while did not change the absolute number of total
thymic DCs and significantly increased MHC-II expression in
this population normally down-regulated in Rag2R229Q/R229Q
mice respect to WT counterpart (Figure 2B). More interestingly,
anti-CD3ε mAb treatment induced a redistribution of the two
thymic DCs main subsets CD8− (myeloid) and CD8+ (lymphoid)
(Figure 2C). The improvement of thymic stroma architecture and
maturation were associated with a reduction in tissue infiltrates,
as demonstrated by the reduced frequency of CD4+ and CD8+
cells in the skin, gut, lung, and liver. Altogether, these data indi-
cate that treatment with anti-CD3ε mAb has a beneficial effect
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on thymic stroma and on peripheral immunopathology, and may
pave the way for similar therapeutic modalities aiming at improv-
ing immune function and reducing signs of immune dysregulation
in patients with SCID characterized by poor thymic maturation,
while waiting for definitive treatment based on hematopoietic cell
transplantation.
CONCLUSION
Thymocytes and TEC cross-talk are fundamental for the main-
tenance of thymic architecture and function. Investigation on
thymic morphology and immunophenotype in SCID patients and
in parallel analysis of murine models of OS and Leaky SCID
have revealed the extent to which altered thymic cross-talk might
lead to immune dysregulation and ultimately cause peripheral
immunopathology. Thymic stromal improvement and amelio-
ration of peripheral immunopathology upon anti-CD3ε mAb
administration in OS mouse model have further highlighted the
contribution of thymic stroma in the pathogenesis of immune
dysregulation. In parallel, poor immunological reconstitution
observed in the preclinical study of gene therapy caused by inad-
equate Rag1 expression has further emphasized the relevance of
stromal thymic compartment in the induction and maintenance
of immune tolerance. Overall these findings further define the role
of thymic epithelium in immune reconstitution and indicate that
cTECs and mTECs full restoration has to be achieved to prevent
immune dysregulation.
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